Diagnostics company Protagen and biopharmaceutical firm SuppreMol announced a collaboration this week to identify therapy-related biomarkers in patients with systemic lupus erythematosus.

According to a statement from SuppreMol CEO Peter Buckel, the company plans to use Protagen's UNIarray technology to identify autoantibody signatures of SLE patients enrolled in a phase IIa study of its lead therapeutic SM101.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PNAS this week: microbial communities of household dust, sequencing study of desiccation tolerance in the Resurrection Plant, and more.

Stanford University's Karl Deisseroth and Xiaoliang Sunney Xie from Harvard University are this year's recipients of the Albany Medical Center Prize.

Penn State researchers home in on a gene linked to the melting point of chocolate.

Researchers plan to share Ebola and MERS viral sequence data more quickly.